Neumirna Therapeutics ApS
Developing miRNA-based therapies to treat complex neurological disease root causes.
Oversigt
- 9
- Medarbejdere
- Ukendt
- Omsætning
- 2020
- Grundlagt
Nøglebeslutningstagere
Andreas Wallnöfer
Independent Board Member
Ina Brünig-Traebert
Chief Development Officer
Manuel Toledo
Scientific Advisory Board Member
Henrik Klitgaard
Co-Founder
+9 flere kontakter i Funnelfeedr
Beskrivelse
Neumirna is a biotechnology company founded in 2020 that specializes in developing miRNA-based therapies to address the root causes of neurological disorders. \n The company focuses on restoring neural network balance by targeting microRNAs, which are critical regulators of gene expression. \n Their...